MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, IMDX has $43,937K in assets. $53,133K in debts. $18,692K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
279.23%
Quick Ratio
273.08%
Cash Ratio
244.02%
Debt to Asset Ratio
120.93%
Assets Breakdown
    • Cash and cash equivalents
    • Intangible assets, net
    • Machinery and equipment, net, an...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Common stock, no par value, 230,...
    • Contingent consideration liabili...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
18,692 24,287
Accounts receivable, net of allowance for credit losses of 3 and 16, respectively
258 512
Inventories
471 693
Restricted cash, current
729 -
Prepaid expenses and other current assets
1,239 1,350
Total current assets
21,389 26,842
Right-of-use and financing lease assets, net
2,340 2,524
Machinery and equipment, net, and construction in progress
4,147 4,149
Intangible assets, net
14,600 14,600
Restricted cash, noncurrent
789 1,700
Other noncurrent assets
672 702
Total assets
43,937 50,517
Accounts payable
1,056 1,277
Accrued compensation
2,228 1,459
Accrued royalties
1,120 1,116
Accrued expenses and other current liabilities
602 571
Right-of-use and financing lease liabilities, current
1,598 1,540
Contingent consideration liabilities, current
1,056 689
Total current liabilities
7,660 6,652
Right-of-use and financing lease liabilities, noncurrent
1,529 1,834
Contingent consideration liabilities, noncurrent
43,944 40,933
Preferred stock, no par value, 5,000 shares authorized no shares issued and outstanding
-0
Total liabilities
53,133 49,419
Common stock, no par value, 230,000 shares authorized 28,625 and 17,453 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
368,524 367,965
Accumulated other comprehensive income
86 85
Accumulated deficit
-377,806 -366,952
Total shareholders' deficit
-9,196 1,098
Total liabilities and shareholders' deficit
43,937 50,517
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$1,239K Restricted cash, current$729K Inventories$471K Accounts receivable, netof allowance for...$258K Cash and cashequivalents$18,692K Other noncurrentassets$672K Restricted cash,noncurrent$789K Intangible assets, net$14,600K Machinery and equipment,net, and...$4,147K Right-of-use and financinglease assets, net$2,340K Total current assets$21,389K Total assets$43,937K Accumulated deficit-$377,806K Total liabilities andshareholders' deficit$43,937K Total shareholders'deficit-$9,196K Accumulated othercomprehensive income$86K Common stock, no parvalue, 230,000 shares...$368,524K Total liabilities$53,133K Contingent considerationliabilities, noncurrent$43,944K Right-of-use and financinglease liabilities,...$1,529K Total currentliabilities$7,660K Contingent considerationliabilities, current$1,056K Right-of-use and financinglease liabilities,...$1,598K Accrued expenses andother current...$602K Accrued royalties$1,120K Accrued compensation$2,228K Accounts payable$1,056K

Insight Molecular Diagnostics Inc. (IMDX)

Insight Molecular Diagnostics Inc. (IMDX)